Impact of radiotherapy pattern on the prognosis of stage IV lung adenocarcinomas harboring EGFR mutations

被引：0
|
作者：
Zhang, Y. [1 ]
Wang, W. [1 ]
Li, J. [1 ]
Li, Z. [1 ]
Li, Y. [2 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Shandong Univ, Cheeloo Coll Med, Dept Radiat Oncol, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1839
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1234P
引用
收藏
页码：S976 / S976
页数：1
相关论文
共 50 条
  • [21] EGFR and KRAS mutations in metastatic Lung adenocarcinomas
    Munfus-McCray, Delicia
    Harada, Shuko
    Adams, Christina
    Askin, Frederic
    Clark, Douglas
    Gabrielson, Edward
    Li, Qing Kay
    HUMAN PATHOLOGY, 2011, 42 (10) : 1447 - 1453
  • [22] Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations
    Hu Yan
    Ren Siying
    Chen Chen
    Liang Qingchun
    Yu Fenglei
    Liu Wenliang
    THORACIC CANCER, 2020, 11 (07) : 2018 - 2022
  • [23] Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
    Paik, Paul K.
    Arcila, Maria E.
    Fara, Michael
    Sima, Camelia S.
    Miller, Vincent A.
    Kris, Mark G.
    Ladanyi, Marc
    Riely, Gregory J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2046 - 2051
  • [24] EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation
    Wang, Y.
    Yu, W.
    Shi, J.
    Qiu, M.
    Jiang, N.
    Wang, Z.
    Yang, J.
    Song, M.
    Jia, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S976 - S976
  • [25] Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations
    Di He
    Di Wang
    Ping Lu
    Nan Yang
    Zhigang Xue
    Xianmin Zhu
    Peng Zhang
    Guoping Fan
    Oncogene, 2021, 40 : 355 - 368
  • [26] Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations
    He, Di
    Wang, Di
    Lu, Ping
    Yang, Nan
    Xue, Zhigang
    Zhu, Xianmin
    Zhang, Peng
    Fan, Guoping
    ONCOGENE, 2021, 40 (02) : 355 - 368
  • [27] Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs
    Gu, Zhenbang
    Huang, Peng
    Zhao, Jiali
    Luo, Chen
    Liao, Lingmin
    Liu, Anwen
    Huang, Long
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (11) : 1979 - 1986
  • [28] Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations
    Ninomiya, Kiichiro
    Teraoka, Shunsuke
    Zenke, Yoshitaka
    Kenmotsu, Hirotsugu
    Nakamura, Yukiko
    Okuma, Yusuke
    Tamiya, Akihiro
    Nosaki, Kaname
    Morise, Masahiro
    Aokage, Keiju
    Oya, Yuko
    Kozuki, Toshiyuki
    Sakamoto, Tomohiro
    Tanaka, Kentaro
    Tanaka, Hisashi
    Tanizaki, Junko
    Miura, Satoru
    Mizutani, Hideaki
    Miyauchi, Eisaku
    Yamaguchi, Ou
    Ebi, Noriyuki
    Goto, Yasushi
    Sasaki, Takaaki
    Daga, Haruko
    Morita, Satoshi
    Yamanaka, Takeharu
    Amano, Shinsuke
    Hasegawa, Kazuo
    Imamura, Chiyo K.
    Suzuki, Kenichi
    Nakajima, Kazuko
    Nishimoto, Hitomi
    Oizumi, Satoshi
    Hida, Toyoaki
    Hotta, Katsuyuki
    Takiguchi, Yuichi
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (01):
  • [29] The Prognostic Impact of EGFR, KRAS and TP53 Somatic Mutations in Curatively Resected Early-Stage Lung Adenocarcinomas
    Rothberg, Bonnie Gould
    Das, Rahul
    Jackson, Laura
    Lazowski, Heather
    Bai, Yalai
    O'Neill, Daniel
    Roberts, Sophia
    Rothberg, Jonathan
    Herbst, Roy
    Kim, Anthony
    Boffa, Daniel
    Rimm, David
    Detterbeck, Frank
    Tanoue, Lynn
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S623 - S624
  • [30] The Impact of Eligibility for Anti-Angiogenic Treatment to the Prognosis of Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Kodama, H.
    Kenmotsu, H.
    Yabe, M.
    Nishioka, N.
    Miyawaki, E.
    Miyawaki, T.
    Mamesaya, N.
    Kobayashi, H.
    Omori, S.
    Wakuda, K.
    Ono, A.
    Naito, T.
    Murakami, H.
    Takahashi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S618 - S618
12345